(Q41344747)

29 September 2017

1 reference

title

Beta-interferon and multiple sclerosis (English)

1 reference

29 September 2017

0 references

Hall GL

1

1 reference

29 September 2017

Compston A

series ordinal

2

1 reference

29 September 2017

Scolding NJ

series ordinal

3

1 reference

29 September 2017

language of work or name

1 reference

1 February 1997

1 reference

29 September 2017

published in

Trends in Neurosciences

1 reference

29 September 2017

volume

20

1 reference

29 September 2017

issue

2

1 reference

29 September 2017

page(s)

63-67

1 reference

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

The pathogenesis of demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

T Regulator Cell Surface Antigens in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

T Cell Subsets in Patients with Multiple Sclerosis: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Evaluation of Leukocyte Surface Antigens in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Suppressor T Cells in MS: Do Changes in Numbers Vary with Clinical Activity?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

The Failure of Monoclonal Antibody-defined Lymphocyte Subsets to Monitor Disease Activity in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Interferon beta augments suppressor cell function in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Immunopharmacologic modulation of experimental allergic encephalomyelitis: low-dose cyclosporin-A treatment causes disease relapse and increased systemic T and B cell-mediated myelin-directed autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Modulation of adhesion of lymphocytes to murine brain endothelial cells in vitro: relation to class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Interferon-β downregulates interferon-γ-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Immune and non-immune actions of interferon-beta-Ib on primary human neural cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Antigen presentation by rat brain and retinal endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Demonstration of alpha, beta, and gamma interferon in active chronic multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Induction of primary T cell responses by human glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Counteracting effect of interferon-alpha and -beta on interferon- gamma-induced production of nitric oxide which is suppressive for antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Exogenous and endogenous type I interferons inhibit interferon-gamma-induced nitric oxide production and nitric oxide synthase expression in murine peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and -beta by murine macrophages for induction of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Functional antagonism between type I and type II interferons on human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Stimulation of macrophage synthesis of complement C1q by interferon-gamma mediated by endogenous interferon-alpha/beta

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Suppression of experimental allergic encephalomyelitis by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

Does interferon beta cause initial exacerbation of multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2910071-0

7 January 2021

10.1016/S0166-2236(96)10071-0

Identifiers

DOI

1 reference

release_fh36w2lcczbd3oj7pzfki32fyy

29 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fh36w2lcczbd3oj7pzfki32fyy

24 November 2022

mapped directly with Wikidata item

1 reference